SG/CALL/ABBOTT LABORATORIES/130/0.1/20.12.24 Stock

Warrant

DE000SQ494X8

Delayed Deutsche Boerse AG 15:41:05 2024-06-26 EDT
0.073 EUR -2.67% Intraday chart for SG/CALL/ABBOTT LABORATORIES/130/0.1/20.12.24
Current month-3.85%
1 month-21.88%
Date Price Change
24-06-26 0.073 -2.67%
24-06-25 0.075 -6.25%
24-06-24 0.08 -11.11%
24-06-21 0.09 -25.00%
24-06-20 0.12 +57.89%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 03:41 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ494X
ISINDE000SQ494X8
Date issued 2022-12-09
Strike 130 $
Maturity 2024-12-20 (177 Days)
Parity 10 : 1
Emission price 0.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.25
Lowest since issue 0.06
Spread 0.01
Spread %12.20%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.5 USD
Average target price
125.2 USD
Spread / Average Target
+18.64%
Consensus